Submitted:
12 May 2025
Posted:
13 May 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
2.1. Study Design and Sample
2.2. Resistance Training Protocol
2.3. Dependent Variables
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| RT | Resistance Training |
| ELAS | Elastic Group |
| TRAD | Traditional Exercise Group |
| DSQ | DePaul Symptom Questionnaire – COVID |
| WHO | World Health Organization |
| BMI | Body Mass Index |
| SBP | Sistolic Blood Pressure |
| DBP | Diastolic Blood Pressure |
| 5TST | Five Times Sit To Stand Test |
| TUG | Timed Up and Go |
| HGS | Hand Grip Strength |
| RHGS | Relative Hand Grip Strength |
| 6MW | Six Minutes Walk |
References
- World Health Organization, ‘WHO COVID-19 dashboard’. Accessed: Mar. 22, 2025. [Online]. Available online: https://data.who.int/dashboards/covid19/deaths?n=o.
- C. N. S. Oliveira, ‘O dimorfismo sexual e regulação imunoendócrina na COVID-19’, Universidade de São Paulo, Ribeirão Preto, 2022. [CrossRef]
- R. K. Ochani et al., ‘COVID-19 pandemic: from origins to outcomes. A comprehensive review of viral pathogenesis, clinical manifestations, diagnostic evaluation, and management’, 2021.
- M. N. Soares et al., ‘Skeletal muscle alterations in patients with acute Covid-19 and post-acute sequelae of Covid-19’, Feb. 01, 2022, John Wiley and Sons Inc. [CrossRef]
- B. Bigdelou et al., ‘COVID-19 and Preexisting Comorbidities: Risks, Synergies, and Clinical Outcomes’, Front Immunol, vol. 13, May 2022. [CrossRef]
- E. W. Ely, L. M. Brown, and H. V Fineberg, ‘Long Covid Defined’, New England Journal of Medicine, vol. 18, no. 391, pp. 1746–1753, Nov. 2024. [CrossRef]
- C. Chen, S. R. Haupert, L. Zimmermann, X. Shi, L. G. Fritsche, and B. Mukherjee, ‘Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review’, Journal of Infectious Diseases, vol. 226, no. 9, pp. 1593–1607, Nov. 2022. [CrossRef]
- J. Klein et al., ‘Distinguishing features of long COVID identified through immune profiling’, Nature, vol. 623, no. 7985, pp. 139–148, Nov. 2023. [CrossRef]
- T. Greenhalgh, M. Sivan, A. Perlowski, and J. Nikolich, ‘Long COVID: a clinical update’, Aug. 17, 2024, Elsevier B.V. [CrossRef]
- N. Salari et al., ‘Global prevalence of chronic fatigue syndrome among long COVID-19 patients: A systematic review and meta-analysis’, Biopsychosoc Med, vol. 16, no. 1, Dec. 2022. [CrossRef]
- S. Gil et al., ‘Muscle strength and muscle mass as predictors of hospital length of stay in patients with moderate to severe COVID-19: a prospective observational study’, J Cachexia Sarcopenia Muscle, vol. 12, no. 6, pp. 1871–1878, Dec. 2021. [CrossRef]
- P. Lopez et al., ‘Resistance Training Load Effects on Muscle Hypertrophy and Strength Gain: Systematic Review and Network Meta-analysis’, Jun. 01, 2021, Lippincott Williams and Wilkins. [CrossRef]
- D. V. Pouliopoulou et al., ‘Rehabilitation Interventions for Physical Capacity and Quality of Life in Adults With Post–COVID-19 Condition A Systematic Review and Meta-Analysis’, JAMA Netw Open, vol. 6, no. 9, Sep. 2023. [CrossRef]
- W. R. Martins, R. J. de Oliveira, R. S. Carvalho, V. de Oliveira Damasceno, V. Z. M. da Silva, and M. S. Silva, ‘Elastic resistance training to increase muscle strength in elderly: A systematic review with meta-analysis’, 2013. [CrossRef]
- J. DeMars et al., ‘What is Safe Long COVID Rehabilitation?’, 2023. [CrossRef]
- L. A. Jason and J. A. Dorri, ‘ME/CFS and Post-Exertional Malaise among Patients with Long COVID’, Neurol Int, vol. 15, no. 1, 2023. [CrossRef]
- T. Abe, D. V. DeHoyos, M. L. Pollock, and L. Garzarella, ‘Time course for strength and muscle thickness changes following upper and lower body resistance training in men and women’, Eur J Appl Physiol Occup Physiol, vol. 81, no. 3, 2000. [CrossRef]
- M. M. Reis and P. M. M. Arantes, ‘Medida da força de preensão manual – validade e confiabilidade do dinamômetro saehan’, Fisioterapia e Pesquisa, vol. 18, no. 2, pp. 176–181, 2011.
- I. da S. Almeida et al., ‘A medida da força muscular relativa de preensão manual representa a força muscular global em idosas?’, Research, Society and Development, vol. 11, no. 11, p. e560111134018, Sep. 2022. [CrossRef]
- American Lung Association, ‘Pulmonary Exercise Tests’. Accessed: Mar. 22, 2025. [Online]. Available online: https://www.lung.org/lung-health-diseases/lung-procedures-and-tests/pulmonary-exercise-test.
- Centers for Disease Control and Prevention, ‘Timed Up & Go (TUG)’. Accessed: Mar. 22, 2025. [Online]. Available online: https://www.cdc.gov/steadi/media/pdfs/steadi-assessment-tug-508.pdf.
- T. A. De Melo, A. C. M. Duarte, T. S. Bezerra, F. França, N. S. Soares, and D. Brito, ‘The five times sit-to-stand test: Safety and reliability with older intensive care unit patients at discharge’, Rev Bras Ter Intensiva, vol. 31, no. 1, 2019. [CrossRef]
- A. A. Ibrahim, I. M. Dewir, S. T. Abu El Kasem, M. M. Ragab, M. S. Abdel-Fattah, and H. M. Hussein, ‘Influences of high vs. low-intensity exercises on muscle strength, function, and quality of life in post-COVID-19 patients with sarcopenia: a randomized controlled trial’, Eur Rev Med Pharmacol Sci, no. 27, pp. 9530–9539, 2023.
- K. Kaczmarczyk, Y. Matharu, P. Bobowik, J. Gajewski, A. Maciejewska-Skrendo, and K. Kulig, ‘Resistance Exercise Program Is Feasible and Effective in Improving Functional Strength in Post-COVID Survivors’, J Clin Med, vol. 13, no. 6, Mar. 2024. [CrossRef]
- R. Ramírez-Vélez et al., ‘Exercise training in long COVID: the EXER-COVID trial’, Eur Heart J, Nov. 2024. [CrossRef]
- H. E. Davis, L. McCorkell, J. M. Vogel, and E. J. Topol, ‘Long COVID: major findings, mechanisms and recommendations’, Nat Rev Microbiol, vol. 21, no. 3, pp. 133–146, Mar. 2023. [CrossRef]
- H. L. Corrêa et al., ‘Post-exercise hypotension following different resistance exercise protocols’, Sport Sci Health, vol. 18, no. 2, pp. 357–365, 2022. [CrossRef]
- R. Gloeckl et al., ‘Practical Recommendations for Exercise Training in Patients with Long COVID with or without Post-exertional Malaise: A Best Practice Proposal’, Sports Med Open, vol. 10, no. 1, Dec. 2024. [CrossRef]
- K. Kaczmarczyk, K. Płoszczyca, K. Jaskulski, and M. Czuba, ‘Eight Weeks of Resistance Training Is Not a Sufficient Stimulus to Improve Body Composition in Post-COVID-19 Elderly Adults’, J Clin Med, vol. 14, no. 1, Jan. 2025. [CrossRef]
- B. J. Schoenfeld, ‘Squatting kinematics and kinetics and their application to exercise performance’, 2010. [CrossRef]


| Group | ||||
|---|---|---|---|---|
| Pre-intervention | Total (n=8) | ELAS (n=4) | TRAD (n=4) | P value |
| Age (years) | 46.8 ± 14.8 | 42.8 ± 15.6 | 50.8 ± 15 | 0.48 |
| Height (cm) | 165.4 ± 8.1 | 166.4 ± 10.8 | 164.3 ± 5.8 | 0.74 |
| Body mass (kg) | 75.5 ± 12.8 | 79.2 ± 8.9 | 71.8 ± 16.3 | 0.45 |
| BMI (kg•m-2) | 27.7 ± 5.3 | 29.1 ± 6.4 | 26.4 ± 4.6 | 0.52 |
| Body fat % | 36.6 ± 11.8 | 37.9 ± 16.3 | 34.8 ± 7.2 | 0.73 |
| Muscle mass % | 28.2 ± 6.9 | 28.2 ± 9.7 | 28.2 ± 4.2 | 0.98 |
| SBP (mm•Hg-1) | 129.7 ± 12.2 | 129 ± 6.5 | 130.4 ± 17.5 | 0.88 |
| DBP (mm•Hg-1) | 88.3 ± 10.1 | 89.8 ± 5.5 | 86.8 ± 14.2 | 0.70 |
| Uric acid (mg•dl-1) | 5.9 ± 1.4 | 5.2 ± 0.72 | 6.6 ± 1.8 | 0.20 |
| Blood glucose (mg•dl-1) | 92.3 ± 8.9 | 90.2 ± 8 | 94.5 ± 10.4 | 0.54 |
| DSQ-COVID (AU) | 1215.6 ± 323 | 1400 ± 289.9 | 1031.2 ± 262.3 | 0.10 |
| 5TSTS (s) | 10.7 ± 2.8 | 10.5 ± 3.8 | 10.9 ± 2.1 | 0.86 |
| TUG (s) | 8.6 ± 1.9 | 8.6 ± 1 | 8.6 ± 2.7 | 0.99 |
| HGS (kg•f-1) | 31.2 ± 8.8 | 30.7 ± 10.2 | 31.7 ± 8.8 | 0.88 |
| RHGS (AU) | 1.1 ± 0.4 | 1.1 ± 0.5 | 1.1 ± 0.1 | 0.88 |
| 6MW (m) | 449.5 ± 83.1 | 444.1 ± 94.8 | 454.9 ± 84.1 | 0.87 |
| Muscle thickness (mm)* | 26 ± 5.7 | 24.6 (23.8 – 27.4) | 25.9 (23.1 – 28.1) | 0.88 |
| Variable | Before | After 12 weeks | P value | Effect size |
| Body mass (kg) | 75.5 ± 12.8 | 76.9 ± 12.6 | 0.062 | 0.56 |
| BMI (kg/m2) | 27.7 ± 5.3 | 28.2 ± 5.5 | 0.105 | 0.47 |
| Body fat % | 36.3 ± 11.8 | 36.1 ± 12.1 | 0.593 | 0.24 |
| Muscle mass % | 28.2 ± 6.9 | 28.5 ± 7 | 0.246 | 0.009 |
| SBP (mm/Hg) | 129.7 ± 12.2 | 116.6 ± 11.2 | 0.040† | -0.10 |
| DBP (mm/Hg) | 88.3 ± 10.1 | 79.9 ± 8.6 | 0.060 | 0.28 |
| Uric acid (mg/dl) | 5.9 ± 1.4 | 6.11 ± 1.8 | 0.589 | -1.0 |
| Blood glucose (mg/dl) | 92.3 ± 8.9 | 95.4 ± 10.7 | 0.470 | -0.45 |
| DSQ-COVID (AU) | 1215.6 ± 323.0 | 671.8 ± 398.4 | 0.006† | 1.33 |
| 5TSTS (s) | 10.7 ± 2.8 | 9.8 ± 2.3 | 0.198 | -0.12 |
| TUG (s) | 8.6 ± 1.9 | 7.8 ± 1.5 | 0.109 | -0.009 |
| HGS (kg/f) | 31.2 ± 8.8 | 35.3 ± 8.5 | 0.012† | -0.10 |
| RHGS | 1.16 ± 0.4 | 1.28 ± 0.3 | 0.039† | -0.10 |
| 6MW (m) | 449.5 ± 83.1 | 492.5 ± 47.3 | 0.097 | -0.12 |
| Muscle Thickness (mm)* | 25.4 (23.8 – 28.1) | 24 (22.6 – 27.9) | 1.000 | 0.22 |
| Variable | Mean ± SD | Minimum | Maximum |
| Body mass (kg) | 1.9 ± 2.2 | -1.5 | 4.9 |
| BMI (kg/m2) | 1.8 ± 2.5 | -2.5 | 4.8 |
| Body fat % | -0.8 ± 2.86 | -5.1 | 2.4 |
| Muscle mass % | 0.4 (-0.2 – 1.2) | -1.5 | 7.7 |
| SBP (mm/Hg) | -9.5 ± 10.6 | -27.6 | 4.0 |
| DBP (mm/Hg) | -8.9 ± 11.1 | -26.6 | 10.2 |
| Uric Acid (mg/dl) | 2.6 ± 16.1 | -17.3 | 23.7 |
| Blood glucose (mg/dl) | 3.6 ± 12.3 | -11.2 | 26.7 |
| 5TSTS (s) | -5.9 ± 17.4 | -22.8 | 23.5 |
| TUG (s) | -8.2 ± 13.6 | -21.3 | 20.8 |
| HGS (kg/f) | 14.3 ± 12.1 | -2.1 | 33.3 |
| RHGS (kgf/bmi) | 12.3 ± 12.7 | -3.8 | 32.5 |
| 6MW (m) | 11.8 ± 16.6 | -10.1 | 39.2 |
| Muscle Thickness (mm) | -0.6 ± 8.3 | -12.5 | 10.6 |
| DSQ-COVID (AU) | -45.3 ± 27.6 | -85.7 | -12.0 |
| Fatigue/extreme tiredness (AU) | -53.1 ± 25.7 | -25.0 | -87.5 |
| Bone or joint pain (AU) | -48.4 ± 28.7 | -25.0 | -100.0 |
| Memory loss (AU)* | -50.0 (46.9 – 53.1) | -37.5 | -100.0 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).